miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

被引:197
作者
Fabani, Martin M. [1 ]
Gait, Michael J. [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
microRNA; miR-122; PNA; antisense; peptide; targeting;
D O I
10.1261/rna.844108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
MicroRNAs are small noncoding RNAs that regulate many cellular processes in a post-transcriptional mode. MicroRNA knockdown by antisense oligonucleotides is a useful strategy to explore microRNA functionality and as potential therapeutics. MicroRNA-122 (miR-122) is a liver-specific microRNA, the main function of which has been linked with lipid metabolism and liver homeostasis. Here, we show that lipofection of an antisense oligonucleotide based on a Locked Nucleic Acids (LNA)/2'-O-methyl mixmer or electroporation of a Peptide Nucleic Acid (PNA) oligomer is effective at blocking miR-122 activity in human and rat liver cells. These oligonucleotide analogs, evaluated for the first time in microRNA inhibition, are more effective than standard 2'-O-methyl oligonucleotides in binding and inhibiting microRNA action. We also show that microRNA inhibition can be achieved without the need for transfection or electroporation of the human or rat cell lines, by conjugation of an antisense PNA to the cell-penetrating peptide R-6-Penetratin, or merely by linkage to just four Lys residues, highlighting the potential of PNA for future therapeutic applications as well as for studying microRNA function.
引用
收藏
页码:336 / 346
页数:11
相关论文
共 38 条
[1]
Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates [J].
Abes, S ;
Williams, D ;
Prevot, P ;
Thierry, A ;
Gait, MJ ;
Lebleu, B .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (03) :595-604
[2]
Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid [J].
Albertshofer, K ;
Siwkowski, AM ;
Wancewicz, EV ;
Esau, CC ;
Watanabe, T ;
Nishihara, KC ;
Kinberger, GA ;
Malik, L ;
Eldrup, AB ;
Manoharan, M ;
Geary, RS ;
Monia, BP ;
Swayze, EE ;
Griffey, RH ;
Bennett, CF ;
Maier, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6741-6749
[3]
Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides [J].
Arzumanov, A ;
Walsh, AP ;
Rajwanshi, VK ;
Kumar, R ;
Wengel, J ;
Gait, MJ .
BIOCHEMISTRY, 2001, 40 (48) :14645-14654
[4]
Therapeutically promising PNA complementary to a regulatory sequence for c-myc:: Pharmacokinetics in an animal model of human Burkitt's lymphoma [J].
Boffa, LC ;
Cutrona, G ;
Cilli, M ;
Mariani, MR ;
Matis, S ;
Pastorino, M ;
Damonte, G ;
Millo, E ;
Roncella, S ;
Ferrarini, L .
OLIGONUCLEOTIDES, 2005, 15 (02) :85-93
[5]
Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs [J].
Brown, D ;
Arzumanov, AA ;
Turner, JJ ;
Stetsenko, DA ;
Lever, AML ;
Gait, MJ .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7) :393-396
[7]
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[8]
Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066
[9]
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis [J].
Cheng, AM ;
Byrom, MW ;
Shelton, J ;
Ford, LP .
NUCLEIC ACIDS RESEARCH, 2005, 33 (04) :1290-1297
[10]
MicroRNA-143 regulates adipocyte differentiation [J].
Esau, C ;
Kang, XL ;
Peralta, E ;
Hanson, E ;
Marcusson, EG ;
Ravichandran, LV ;
Sun, YQ ;
Koo, S ;
Perera, RJ ;
Jain, R ;
Dean, NM ;
Freier, SM ;
Bennett, CF ;
Lollo, B ;
Griffey, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52361-52365